Merck Net Income 2006-2019 | MKGAF

Merck annual/quarterly net income history and growth rate from 2006 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Merck net income for the quarter ending March 31, 2019 was $0.215B, a 48.79% decline year-over-year.
  • Merck net income for the twelve months ending March 31, 2019 was $3.780B, a 34.88% increase year-over-year.
  • Merck annual net income for 2018 was $3.985B, a 35.59% increase from 2017.
  • Merck annual net income for 2017 was $2.939B, a 63.03% increase from 2016.
  • Merck annual net income for 2016 was $1.803B, a 45.72% increase from 2015.
Merck Annual Net Income
(Millions of US $)
2018 $3,985
2017 $2,939
2016 $1,803
2015 $1,237
2014 $1,548
2013 $1,606
2012 $745
2011 $876
2010 $839
2009 $511
2008 $540
2007 $4,799
2006 $1,235
2005 $820
Merck Quarterly Net Income
(Millions of US $)
2019-03-31 $215
2018-12-31 $2,876
2018-09-30 $395
2018-06-30 $295
2018-03-31 $419
2017-12-31 $1,162
2017-09-30 $758
2017-06-30 $463
2017-03-31 $555
2016-12-31 $288
2016-09-30 $510
2016-06-30 $352
2016-03-31 $652
2015-12-31 $138
2015-09-30 $407
2015-06-30 $380
2015-03-31 $321
2014-12-31 $313
2014-09-30 $331
2014-06-30 $405
2014-03-31 $446
2013-12-31 $382
2013-09-30 $450
2013-06-30 $419
2013-03-31 $345
2012-12-31 $350
2012-09-30 $232
2012-06-30 $-78
2012-03-31 $222
2011-12-31 $178
2011-09-30 $321
2011-06-30 $-124
2011-03-31 $466
2010-12-31 $89
2010-09-30 $272
2010-06-30 $224
2010-03-31 $255
2009-12-31 $82
2009-09-30 $206
2009-06-30 $148
2009-03-31 $75
2008-12-31 $-444
2008-09-30 $302
2008-06-30 $324
2008-03-31 $358
2007-12-31 $4,645
2007-09-30 $50
2007-06-30 $115
2007-03-31 $-11
2006-12-31 $169
2006-09-30 $184
2006-06-30 $664
2006-03-31 $218
2005-12-31 $129
2005-09-30 $221
2005-06-30 $313
2005-03-31 $157
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.525B $18.092B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $55.415B 32.06
Takeda Pharmaceutical (TAK) Japan $49.277B 8.64
Astellas Pharma (ALPMY) Japan $30.146B 15.06
Eisai (ESALY) Japan $21.608B 40.25
UCB SA (UCBJF) Belgium $16.296B 0.00
Grifols, S.A (GRFS) Spain $14.164B 17.61
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.453B 234.85
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.387B 30.39
Ionis Pharmaceuticals (IONS) United States $6.712B 20.34
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.721B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.591B 6.82
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.593B 0.00
IPSEN SA ADR (IPSEY) France $4.511B 0.00
United Therapeutics (UTHR) United States $4.260B 0.00
Hypermarcas (HYPMY) Brazil $3.661B 11.14
Evotec AG (EVTCY) Germany $3.485B 56.21
Nektar Therapeutics (NKTR) United States $3.207B 0.00
FibroGen (FGEN) United States $3.083B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.945B 54.66
PTC Therapeutics (PTCT) United States $2.664B 0.00
ChemoCentryx (CCXI) United States $2.441B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.391B 9.67
Xencor (XNCR) United States $1.736B 70.88
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.651B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.634B 19.86
Sage Therapeutics (SAGE) United States $1.531B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.453B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.417B 38.75
Corcept Therapeutics (CORT) United States $1.341B 15.00
Karyopharm Therapeutics (KPTI) United States $1.312B 0.00
USANA Health Sciences (USNA) United States $1.249B 13.11
Zogenix (ZGNX) United States $1.161B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.103B 0.00
Heron Therapeutics (HRTX) United States $1.056B 0.00
Akebia Therapeutics (AKBA) United States $1.034B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.010B 31.29
Esperion Therapeutics (ESPR) United States $0.935B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.919B 12.79
Endo (ENDP) Ireland $0.830B 1.53
Translate Bio (TBIO) United States $0.689B 0.00
Tilray (TLRY) Canada $0.688B 0.00
Molecular Templates (MTEM) United States $0.643B 0.00
Aerie Pharmaceuticals (AERI) United States $0.626B 0.00
ImmunoGen (IMGN) United States $0.619B 0.00
Radius Health (RDUS) United States $0.606B 0.00
Collegium Pharmaceutical (COLL) United States $0.580B 0.00
Portola Pharmaceuticals (PTLA) United States $0.568B 0.00
Indivior (INVVY) United States $0.464B 2.76
Catalyst Pharmaceuticals (CPRX) United States $0.401B 13.38
Corbus Pharmaceuticals Holdings (CRBP) United States $0.399B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.398B 16.35
Siga Technologies (SIGA) United States $0.396B 0.00
Innate Pharma SA (IPHYF) France $0.385B 0.00
Ardelyx (ARDX) United States $0.380B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.371B 0.00
Organogenesis Holdings (ORGO) United States $0.357B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.327B 0.00
Trillium Therapeutics (TRIL) Canada $0.323B 0.00
Flexion Therapeutics (FLXN) United States $0.317B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.307B 0.00
Lannett Co Inc (LCI) United States $0.304B 4.89
Harpoon Therapeutics (HARP) United States $0.294B 0.00
DURECT (DRRX) United States $0.294B 0.00
Calithera Biosciences (CALA) United States $0.294B 0.00
TherapeuticsMD (TXMD) United States $0.291B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.279B 0.00
Concert Pharmaceuticals (CNCE) United States $0.269B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.261B 0.00
Ocular Therapeutix (OCUL) United States $0.260B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.258B 0.00
CASI Pharmaceuticals (CASI) United States $0.207B 0.00
OptiNose (OPTN) United States $0.197B 0.00
Recro Pharma (REPH) United States $0.187B 0.00
Rafael Holdings (RFL) United States $0.179B 0.00
Jounce Therapeutics (JNCE) United States $0.170B 3.06
Nature's Sunshine Products (NATR) United States $0.162B 20.24
PROFOUND MEDICL (PROF) Canada $0.157B 0.00
MEI Pharma (MEIP) United States $0.153B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.138B 0.00
Taiwan Liposome (TLC) Taiwan $0.137B 0.00
KalVista Pharmaceuticals (KALV) United States $0.135B 0.00
VAXART, INC (VXRT) United States $0.120B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.113B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.102B 0.00
Redhill Biopharma (RDHL) Israel $0.096B 0.00
CannTrust Holdings (CTST) Canada $0.090B 0.00
IMV INC (IMV) Canada $0.090B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.088B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.087B 0.00
Champions Oncology (CSBR) United States $0.083B 0.00
Xeris Pharmaceuticals (XERS) United States $0.082B 0.00
Aquestive Therapeutics (AQST) United States $0.076B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.076B 0.00
Hemispherx BioPharma (AIM) United States $0.076B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.074B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
Biomerica (BMRA) United States $0.071B 0.00
CTI BioPharma (CTIC) United States $0.066B 0.00
Otonomy (OTIC) United States $0.064B 0.00
CV Sciences (CVSI) United States $0.062B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.056B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.055B 17.29
ALLERGY THERAPT (AGYTF) United Kingdom $0.055B 0.00
Infinity Pharmaceuticals (INFI) United States $0.048B 0.00
Nivalis Therapeutics (ALPN) United States $0.046B 0.00
PharmAthene (ALT) United States $0.046B 0.00
GTx (ONCT) United States $0.045B 0.00
Natural Alternatives (NAII) United States $0.045B 20.34
Onconova Therapeutics (ONTX) United States $0.043B 0.00
MediWound (MDWD) Israel $0.043B 0.00
Aclaris Therapeutics (ACRS) United States $0.042B 0.00
PolarityTE (PTE) United States $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 134.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Forward Pharma (FWP) Denmark $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.037B 0.00
IsoRay (ISR) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.036B 0.00
AgeX Therapeutics (AGE) United States $0.035B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.035B 0.00
Heat Biologics (HTBX) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.027B 0.00
Mannatechorporated (MTEX) United States $0.026B 8.04
Lipocine (LPCN) United States $0.023B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.023B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Novan (NOVN) United States $0.022B 0.00
Cardiome Pharma (CORV) Canada $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.020B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.020B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
China SXT Pharmaceuticals (SXTC) China $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.012B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Vical (BBI) United States $0.012B 0.00
Can-Fite Biopharma (CANF) Israel $0.011B 0.00
Shineco (TYHT) China $0.011B 0.00
KemPharm (KMPH) United States $0.011B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.003B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00
RXi Pharmaceuticals (PHIO) United States $0.001B 0.00